Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature

Diego Almanza,Mehrnaz Gharaee-Kermani,Alisa Zhilin-Roth,Jose A. Rodriguez-Nieves,Cory Colaneri,Todd Riley,Jill A. Macoska

Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature

2019

Diego Almanza
Mehrnaz Gharaee-Kermani
Alisa Zhilin-Roth
Jose A. Rodriguez-Nieves
Cory Colaneri
Todd Riley
Jill A. Macoska

Background Metabolic syndrome contributing to nonalcoholic fatty liver disease (NAFLD) can lead to hepatic dysfunction, steatohepatitis, cirrhosis, and hepatocellular carcinoma.

Keywords:

Diabetes mellitus
Cirrhosis
Cancer
Medicine
Gastroenterology
Internal medicine
Hepatocellular carcinoma
Steatohepatitis
Endocrinology
Nonalcoholic fatty liver disease
Fibrosis
Metabolic syndrome
Steatosis
Fatty liver
Cancer research
Hepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations